Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.V. Le
Economic Cost of Adverse Events Per Course of Therapy With Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab
OncoTargets and Therapy
Oncology
Pharmacology
Treatment Patterns, Adverse Events, and Economic Burden in a Privately Insured Population of Patients With Chronic Lymphocytic Leukemia in the United States
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Idelalisib for the Treatment of Chronic Lymphocytic Leukemia
ISRN Oncology
Update on Therapy of Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Management of Adverse Events Associated With Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Frontline Therapy for Chronic Lymphocytic Leukemia: The Dilemma Continues
Clinical Cancer Research
Cancer Research
Oncology
Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
Consolidation Treatment With Lenalidomide Following Front-Line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
